Education
About Us
Working with TipRanks
Follow Us
Actinogen Medical Limited (AU:ACW)
:ACW
ACW Stock Chart & Stats
Day’s Range― - ―
52-Week RangeAU$0.02 - AU$0.08
Previous CloseN/A
Volume244.11K
Average Volume (3M)2.68M
Market Cap
AU$76.25M
Enterprise ValueAU$50.36M
Total Cash (Recent Filing)AU$22.87M
Total Debt (Recent Filing)AU$289.64K
Price to Earnings (P/E)―
Beta0.79
Next Earnings
Aug 27, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding3,177,147,200
10 Day Avg. Volume1,105,706
30 Day Avg. Volume2,683,715
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusHold
Number of Analyst Covering0
Actinogen Medical News
ACW FAQ
What was Actinogen Medical Limited’s price range in the past 12 months?
Actinogen Medical Limited lowest share price was AU$0.02 and its highest was AU$0.08 in the past 12 months.
What is Actinogen Medical Limited’s market cap?
Actinogen Medical Limited’s market cap is AU$76.25M.
When is Actinogen Medical Limited’s upcoming earnings report date?
Actinogen Medical Limited’s upcoming earnings report date is Aug 27, 2025 which is in 19 days.
How were Actinogen Medical Limited’s earnings last quarter?
Actinogen Medical Limited released its earnings results on Feb 24, 2025. The company reported -AU$0.003 earnings per share for the quarter, missing the consensus estimate of N/A by -AU$0.003.
Is Actinogen Medical Limited overvalued?
According to Wall Street analysts Actinogen Medical Limited’s price is currently Overvalued.
Does Actinogen Medical Limited pay dividends?
Actinogen Medical Limited does not currently pay dividends.
What is Actinogen Medical Limited’s EPS estimate?
Actinogen Medical Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Actinogen Medical Limited have?
Actinogen Medical Limited has 3,177,147,200 shares outstanding.
What happened to Actinogen Medical Limited’s price movement after its last earnings report?
Actinogen Medical Limited reported an EPS of -AU$0.003 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -9.756%.
Which hedge fund is a major shareholder of Actinogen Medical Limited?
Currently, no hedge funds are holding shares in AU:ACW
Actinogen Medical Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
― (―)
― (―)
Blogger Sentiment
Bullish
AU:ACW Sentiment 70%
Sector Average 71%
Sector Average 71%
News Sentiment
Neutral
Bullish news 59%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Positive
20 days / 200 days
Momentum
78.57%
12-Months-Change
Fundamentals
Return on Equity
-55.44%
Trailing 12-Months
Asset Growth
62.90%
Trailing 12-Months
Company Description
Actinogen Medical Limited
Actinogen Medical (ACW) is a biotechnology company focused on the development and commercialization of innovative treatments for cognitive impairment and other central nervous system (CNS) disorders. The company's lead product, Xanamem, is a promising drug candidate aimed at treating cognitive decline associated with conditions such as Alzheimer's disease and other neurodegenerative diseases. Actinogen Medical operates primarily in the pharmaceutical and biotechnology sectors, leveraging cutting-edge research to address unmet medical needs in CNS disorders.
Technical Analysis
Prescient Therapeutics Limited
―
Alterity Therapeutics
―
Radiopharm Theranostics Limited
―
EZZ Life Science Holdings Ltd.
―
Arovella Therapeutics Limited
―
Ownership Overview
6.71% Insiders
―
Mutual Funds
― Other Institutional Investors
93.29% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---